Association of B-Type Natriuretic Peptide Levels With Estimated Glomerular Filtration Rate and Congestive Heart Failure
- 17 November 2009
- journal article
- Published by Marshfield Clinic Research Institute in Clinical Medicine & Research
- Vol. 8 (1), 7-12
- https://doi.org/10.3121/cmr.2009.867
Abstract
The causes of elevated B-Type natriuretic peptide (BNP) levels are multifactorial. Renal dysfunction has been shown to affect BNP levels in some studies and the diagnostic value of BNP levels in the presence of chronic kidney disease has been questioned. Prior studies have involved small patient populations with variable outcomes noted. This study evaluated the association of BNP levels with an estimated glomerular filtration rate (eGFR) and presence or absence of congestive heart failure (CHF). A retrospective, cross-sectional study in which medical records were electronically screened, identified patients with a BNP level and serum creatinine measurement on the same day between December 2002 and March 2006. Of 1739 eligible patients, 537 were positive for CHF and 1202 were negative for CHF by our criteria. There was a clear trend for BNP to be higher with the advancement of CHF, as determined by New York Heart Association (NYHA) classification (P<0.001). Median BNP levels increased from 65 pg/mL in patients without CHF to 496 pg/mL in patients with NYHA class IV CHF (P <0.001), and there was a strong inverse association with eGFR (P <0.001). BNP levels show a strong inverse association with eGFR in both CHF and non-CHF patients. Currently best practice at most institutions involves use of BNP cutoff diagnostic levels not adjusted for eGFR. The data presented underlines that eGFR is a significant confounder of BNP measurement especially when renal status is compromised and interpretation of clinical significance in the presence of elevated BNP measures should take renal status into consideration.Keywords
This publication has 32 references indexed in Scilit:
- Natriuretic Peptides in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2008
- Relationship between serum brain natriuretic peptide and heart function in patients with chronic kidney diseaseThe Korean Journal of Internal Medicine, 2008
- Natriuretic PeptidesJournal of the American College of Cardiology, 2007
- Impact of Renal Disease on Natriuretic Peptide Testing for Diagnosing Decompensated Heart Failure and Predicting MortalityClinical Chemistry, 2007
- Use of an Electronic Medical Record for the Identification of Research Subjects with Diabetes MellitusClinical Medicine & Research, 2007
- B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in Patients With CKD: Relationship to Renal Function and Left Ventricular HypertrophyAmerican Journal of Kidney Diseases, 2005
- Natriuretic Peptides and the Dialysis PatientSeminars in Dialysis, 2005
- Increased Plasma Concentration of Natriuretic Peptides by Selective β1-Blocker BisoprololJournal of Cardiovascular Pharmacology, 2003
- Brain Natriuretic Peptide Is a Sensitive Indicator of Impaired Left-Ventricular Function in Elderly Patients with Cardiovascular DiseaseJMIR AI, 1997
- Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular HypertrophyHypertension, 1996